Operating
Other Non-Cash Adjustments
Edwards Lifesciences Other Non-Cash Adjustments increased by 90.7% to -$500.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 86.1%, from -$3.60M to -$500.00K. Over 2 years (FY 2021 to FY 2024), Other Non-Cash Adjustments shows a downward trend with a 18.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ1 2026May 6, 2026
Metric ID:
pg_other_noncash_adjustmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.40M | -$1.60M | -$4.10M | -$20.40M | -$1.30M | -$2.30M | -$1.10M | $1.80M | -$9.50M | $0.00 | -$500.00K | -$1.50M | -$700.00K | -$10.50M | -$3.60M | -$4.70M | -$5.40M | -$500.00K |
| QoQ Change | — | +75.0% | -156.3% | -397.6% | +93.6% | -76.9% | +52.2% | +263.6% | -627.8% | +100.0% | — | -200.0% | +53.3% | <-999% | +65.7% | -30.6% | -14.9% | +90.7% |
| YoY Change | — | — | — | — | +18.8% | +43.9% | +94.6% | — | -630.8% | +100.0% | +54.5% | -183.3% | +92.6% | — | -620.0% | -213.3% | +48.6% | +86.1% |
Range-$20.40M – $1.80M
CAGR-45.1%
Avg YoY Growth-92.4%
Median YoY Growth+46.2%
Other Non-Cash Adjustments at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's other non-cash adjustments?
- Edwards Lifesciences (EW) reported other non-cash adjustments of -$500.00K in Q1 2026.
- How has Edwards Lifesciences's other non-cash adjustments changed year-over-year?
- Edwards Lifesciences's other non-cash adjustments increased by 86.1% year-over-year, from -$3.60M to -$500.00K.
- What is the long-term trend for Edwards Lifesciences's other non-cash adjustments?
- Over 2 years (2021 to 2024), Edwards Lifesciences's other non-cash adjustments has grown at a 18.5% compound annual growth rate (CAGR), from -$9.40M to -$13.20M.